Melatonin 20 MG Oral Capsule

DRUG2 trials

Sponsors

Hospital de Clinicas de Porto Alegre, Indonesia University

Conditions

DepressionGenotoxicityNeoadjuvant ChemotherapyOral Squamous Cell CarcinomaPainSleep Disorders, Circadian Rhythm

Phase 2

Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

CompletedNCT03205033

Hospital de Clinicas de Porto AlegreDepression, Genotoxicity, Pain +1

Start: 2016-01-31End: 2017-01-31Updated: 2017-07-02

Phase 3

Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma

CompletedNCT04137627

Indonesia UniversityNeoadjuvant Chemotherapy, Oral Squamous Cell Carcinoma

Start: 2017-07-04End: 2018-12-18Updated: 2019-12-09

Related Papers

Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial

Journal of the Egyptian National Cancer Institute2020-02-2828 citations

The Effects of Melatonin on the Descending Pain Inhibitory System and Neural Plasticity Markers in Breast Cancer Patients Receiving Chemotherapy: Randomized, Double-Blinded, Placebo-Controlled Trial

Frontiers in Pharmacology2019-11-2232 citations